Meet Christelle Huguet
Executive Vice President, Research & Development
“I came to science because I was curious – I loved asking questions and finding answers in the data. It’s not always smooth, but the challenges are worth it when you know the goal is helping people. We’re all patients at some point. Using science to make a difference, whether today or tomorrow, is a privilege that motivates me every day.”
Learn More About Christelle Huguet
Meet Sandra Silvestri
Executive Vice President, Chief Medical Officer
“What drives me is the opportunity to shape medicine and clinical practice that reaches beyond the individual – to improve out comes for entire communities. As a physician, I’ve seen the difference the right treatment and appropriate care can make. Now, I have the privilege of helping to shape clinical practice and bring those treatments to more people,faster than ever before.”
Learn More About Sandra SilvestriA Life in Science
What is it like to work at the forefront of innovation?
From lab discoveries to patient impact, hear directly from the people making it happen. Explore stories from our global R&D and medical teams – and see how purpose drives every step of the journey.
10 March 2025
A Life in Science: Driving Innovation Through Collaboration
17 February 2025
A Life in Science: Following Passions to Transform Healthcare
24 February 2025
A Life in Science: Navigating Uncertainty to Make a Difference
17 March 2025
A Life in Science: Shaping the Future of Precision Medicine
03 March 2025
A Life in Science: The Privilege of Making a Difference
Built to endure: Prince Korah on relentless pursuit of robust drug product development.
Robustness is not a box to check—it’s the foundation of every decision. As a Senior Director in the Pharmaceutical Development function in Ipsen’s drug product development team, Prince Korah focuses on driving the pharmaceutical development strategy by overseeing the end-to-end life cycle of drug products with his team.
Targeting what cannot be seen: Lindsey Rodrigues on the complexity of epigenetics
Targeting what cannot be seen: Lindsey Rodrigues on the complexity of epigenetics or mutated in a particular cancer. We have to ask, ‘do we have an understanding of how this gene works? Can we design a medicine to treat it or to target it?”’
Building better processes, earlier: a chemist’s perspective on innovation and sustainability
Nathan McCormack focuses on the earliest stages of active pharmaceutical ingredient (API) development.
Our partnerships define who we are at Ipsen
Philippe Lopes-Fernandes, EVP, Chief Business Officer on how true collaboration paves the way to innovation.
Our acceleration defines who we are at Ipsen
Christelle Huguet, EVP, Head of Research and Development on harnessing technology to accelerate the journey from discovery to innovative medicine.
Partnering
Our people are the heart of our science, but innovation happens through collaboration. Ipsen’s partnerships span from basic research to clinical development, working with external partners to unlock new possibilities.
Learn more